Amanta Healthcare
Mainboard₹14,994 / 119 Shares
IPO Live Subscription Details (times)
Bids below ₹10L: 176.02x
NII Total: 209.42
IPO Details
Amanta Healthcare IPO is priced between ₹120-126 per equity share, with a face value of ₹10 per share. The company's equity shares will be listed on the Mainboard, and MUFG Intime India Pvt Ltd is managing the issue as the registrar.
The IPO bidding period opened on 1 Sep, 2025, and closed on 3 Sep, 2025. The allotment results will be announced on 4 Sep, 2025, with a tentative listing date set for 8 Sep, 2025.
The total issue comprises 1,00,00,000 shares, amounting to ₹126.0 Cr.
Amanta Healthcare IPO Highlights
| IPO Date | Listing Date | Face Value | Price Band | Lot Size | Fresh Issue | Offer for Sale | Listing At |
|---|---|---|---|---|---|---|---|
| Sep 1, 2025 - Sep 3, 2025 | 8 Sep, 2025 | ₹10 Per Equity Share | ₹120-126 per equity share | 119 Shares | Shares | - | BSE, NSE |
Amanta Healthcare IPO Timeline
Issue Price
₹120-126 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
MUFG Intime India Pvt LtdMarket Lot
Retail: 119 Shares (₹14,994/-)S-HNI: 1,666 Shares (₹2,09,916/-)
B-HNI: 7,973 Shares (₹10,04,598/-)
Lead Manager
Beeline Capital Advisors Pvt LtdIssue Size
1,00,00,000 shares(aggregating up to ₹126.0 Cr)Retail Portion
35% (Number of Retail Applications: 29,412 Approx),(Number of S-HNI Applications : 300 Approx),(Number of B-HNI Applications : 600 Approx)Subscription
82.60 timesAmanta Healthcare IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 25 | 381.76 | 276.09 | 10.50 | 96.39 | 67.56 | 195.00 |
| 31 Mar 24 | 352.12 | 281.61 | 3.63 | 66.29 | 39.46 | 205.23 |
| 31 Mar 23 | 374.06 | 262.70 | -2.11 | 62.88 | 36.05 | 215.66 |
All values are in ₹ Cr.
Amanta Healthcare IPO Valuations
EPS PRE IPO ₹3.64/- | EPS POST IPO ₹2.70/- | PE PRE IPO 34.59 | PE POST IPO 46.59 | ROE 12.42% |
ROCE 13.72% | DEBT EQUITY 2.02 | RONW 10.89% | PAT MARGIN 3.86% | PRICE TO BOOK VALUE 3.77 |
About Company
Established in December 1994, Amanta Healthcare Limited is a pharma firm that focuses on the manufacturing, development, and marketing of a wide range of sterile liquid items, namely parenteral items, packaged in plastic containers using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company also engages in the manufacturing of medical devices.The company produces formulations for fluid therapy, such as IV fluids, diluents, ophthalmic solutions, and respiratory care products. The company also sells irrigation solutions, first-aid items, and eye lubricants in the medical device market.
The company sells products through three business divisions:
National sales
International sales
Product partnering with several foreign and Indian pharma companies.
The company produces more than 45 generic items, selling them under their brand names in India through 320 stockists and distributors.The firm markets products in Africa, Latin America, the UK, and overseas. It has registered its products in 19 countries and meets numerous regulations. During Fiscal 2025, the firm shipped branded goods to 21 countries.
As of March 31, 2025, the firm employs a workforce of 1,718 at its formulation and development and quality laboratory.
Amanta Healthcare IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 20,00,000 | 15,00,000 10,00,000 5,00,000 | 35,00,000 | 70,00,000 |
| Day 1 - 01-09-25 05:00 PM | 0.04 x | 5.82 4.24 x 8.98 x | 6.71 x | 4.61 x |
| Day 2 - 02-09-25 05:00 PM | 0.53 x | 36.40 30.03 x 49.13 x | 23.33 x | 19.62 x |
| Day 3 - 03-09-25 05:00 PM | 35.86 x | 209.40 226.13 x 175.96 x | 54.96 x | 82.60 x |
Retail:46.0x
BHNI:45.0x
SHNI:169.0x times
Amanta Healthcare IPO - Issue Objectives
- Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
- General corporate purposes
Amanta Healthcare
8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058MUFG Intime India Private Limited (Link Intime)
Phone: +91-22-4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html